Emerging impact of quercetin in the treatment of prostate cancer
- PMID: 34311541
- DOI: 10.1016/j.biopha.2021.111548
Emerging impact of quercetin in the treatment of prostate cancer
Abstract
Quercetin is a flavonoid agent detected in fruits and vegetables with anti-inflammatory, antioxidant, and anticancer effects. This flavonoid can suppress cell cycle transition and induce apoptosis in neoplastic cells. Therapeutic effects of quercetin have been assessed in diverse cancers including prostate cancer through the establishment of in vitro and in vivo experiments. Moreover, this agent might prevent the initiation of this type of cancer as it indirectly blocks the activity of promoters of two important genes in the pathogenesis of prostate cancer i.e. androgen receptor (AR) and prostate specific antigen (PSA). Several in vitro investigations have identified the differential influence of quercetin on normal prostate cells versus neoplastic cells, emphasizing its specific cytotoxic effects on cancerous cells. The most appreciated route of quercetin effect on prostate cancer cells is the detachment of Bax from Bcl-xL and the stimulation of caspase families. Besides, quercetin might enhance the effects of other therapeutic options against prostate cancer. For instance, a combination of TNF-related apoptosis-inducing ligand (TRAIL) and quercetin has been recommended as a novel modality for the treatment of prostate cancer. These kinds of strategies might overcome resistance to apoptosis in cancer cells. In the current paper, we summarize the recent data about the preventive and therapeutic influences of quercetin in prostate cancer.
Keywords: Prostate cancer; Quercetin.
Copyright © 2021 The Authors. Published by Elsevier Masson SAS.. All rights reserved.
Similar articles
-
Apoptosis induction in prostate cancer cells and xenografts by combined treatment with Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand and CPT-11.Cancer Res. 2003 Aug 1;63(15):4713-23. Cancer Res. 2003. PMID: 12907654
-
Quercetin-induced growth inhibition and cell death in prostatic carcinoma cells (PC-3) are associated with increase in p21 and hypophosphorylated retinoblastoma proteins expression.J Cancer Res Clin Oncol. 2005 Nov;131(11):765-71. doi: 10.1007/s00432-005-0005-4. Epub 2005 Nov 1. J Cancer Res Clin Oncol. 2005. PMID: 16049707
-
Inhibition of prostate cancer cell colony formation by the flavonoid quercetin correlates with modulation of specific regulatory genes.Clin Diagn Lab Immunol. 2004 Jan;11(1):63-9. doi: 10.1128/cdli.11.1.63-69.2004. Clin Diagn Lab Immunol. 2004. PMID: 14715546 Free PMC article.
-
Quercetin in prostate cancer: Chemotherapeutic and chemopreventive effects, mechanisms and clinical application potential (Review).Oncol Rep. 2015 Jun;33(6):2659-68. doi: 10.3892/or.2015.3886. Epub 2015 Mar 31. Oncol Rep. 2015. PMID: 25845380 Review.
-
Potential of the Flavonoid Quercetin to Prevent and Treat Cancer - Current Status of Research.Klin Onkol. 2018 Spring;31(3):184-190. doi: 10.14735/amko2018184. Klin Onkol. 2018. PMID: 30441971 Review. English.
Cited by
-
Network pharmacology and experimental validation to explore the role and potential mechanism of Liuwei Dihuang Decoction in prostate cancer.BMC Complement Med Ther. 2024 Jul 26;24(1):284. doi: 10.1186/s12906-024-04572-5. BMC Complement Med Ther. 2024. PMID: 39061044 Free PMC article.
-
Multiple Myeloma Inhibitory Activity of Plant Natural Products.Cancers (Basel). 2021 May 29;13(11):2678. doi: 10.3390/cancers13112678. Cancers (Basel). 2021. PMID: 34072312 Free PMC article. Review.
-
Dietary antioxidant quercetin overcomes the acquired resistance of Sorafenib in Sorafenib-resistant hepatocellular carcinoma cells through epidermal growth factor receptor signaling inactivation.Naunyn Schmiedebergs Arch Pharmacol. 2024 Jan;397(1):559-574. doi: 10.1007/s00210-023-02605-3. Epub 2023 Jul 25. Naunyn Schmiedebergs Arch Pharmacol. 2024. PMID: 37490119
-
Molecular targets of exercise mimetics and their natural activators.BMB Rep. 2021 Dec;54(12):581-591. doi: 10.5483/BMBRep.2021.54.12.151. BMB Rep. 2021. PMID: 34814977 Free PMC article. Review.
-
Design of Chitosan-Coated, Quercetin-Loaded PLGA Nanoparticles for Enhanced PSMA-Specific Activity on LnCap Prostate Cancer Cells.Biomedicines. 2023 Apr 18;11(4):1201. doi: 10.3390/biomedicines11041201. Biomedicines. 2023. PMID: 37189819 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous